SHARON SURREY BARBARI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SHARON SURREY BARBARI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SHARON SURREY BARBARI. SHARON SURREY BARBARI is Chief Financial Officer in INTERMUNE INC ($ITMN) and Director in Oculus Innovative Sciences, Inc. ($OCLS) and EVP, Finance & CFO in CYTOKINETICS INC ($CYTK) and Director in AGILE THERAPEUTICS INC ($AGRX) and Director in Menlo Therapeutics Inc. ($MNLO) and Director in Foamix Pharmaceuticals Ltd. ($FOMX).
Latest Insider Trading Transactions of SHARON SURREY BARBARI
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGRX, CYTK, FOMX, ITMN, OCLS, MNLO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21 2020 | MNLO | Menlo Therapeutics ... | BARBARI SHARON | Director | Option Exercise | M | 1.48 | 75,000 | 111,000 | 13,971 | |
| Aug 21 2020 | MNLO | Menlo Therapeutics ... | BARBARI SHARON | Director | Buy | M | 1.48 | 75,000 | 111,000 | 75,000 | 0 to 75 K |
| Aug 05 2020 | MNLO | Menlo Therapeutics ... | BARBARI SHARON | Director | Option Exercise | A | 1.72 | 22,500 | 38,700 | 22,500 | |
| Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | BARBARI SHARON | Director | Option Exercise | A | 2.80 | 45,212 | 126,594 | 45,212 | |
| Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | BARBARI SHARON | Director | Grant | A | 0.00 | 26,786 | 0 | 26,786 | 0 to 26.8 K |
| Mar 23 2020 | MNLO | Menlo Therapeutics ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 2.67 | 45,000 | 120,150 | 45,000 | |
| Mar 11 2020 | MNLO | Menlo Therapeutics ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 4.50 | 29,271 | 131,720 | 29,271 | |
| Mar 11 2020 | FOMX | Foamix Pharmaceuti ... | BARBARI SHARON SURREY | Director | Option Exercise | D | 2.66 | 49,412 | 131,436 | 0 | |
| May 20 2019 | FOMX | Foamix Pharmaceuti ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 2.66 | 49,412 | 131,436 | 49,412 | |
| Mar 02 2018 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 1,424 | 0 | 43,417 | 42 K to 43.4 K (+3.39 %) |
| Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 17,211 | 0 | 41,993 | 24.8 K to 42 K (+69.45 %) |
| Dec 01 2017 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 13,944 | 0 | 24,782 | 10.8 K to 24.8 K (+128.66 %) |
| Aug 30 2017 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 880 | 0 | 10,838 | 10 K to 10.8 K (+8.84 %) |
| Jun 01 2017 | OCLS | Sonoma Pharmaceuti ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 754 | 0 | 9,958 | 9.2 K to 10 K (+8.19 %) |
| Mar 02 2017 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Payment of Exercise | F | 10.60 | 7,317 | 77,560 | 40,323 | 47.6 K to 40.3 K (-15.36 %) |
| Mar 02 2017 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Grant | A | 0.00 | 18,750 | 19 | 47,640 | 28.9 K to 47.6 K (+64.90 %) |
| Nov 30 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 1,035 | 0 | 6,244 | 5.2 K to 6.2 K (+19.87 %) |
| Aug 30 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 1,199 | 0 | 5,209 | 4 K to 5.2 K (+29.90 %) |
| Jun 01 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 4,445 | 0 | 20,051 | 15.6 K to 20.1 K (+28.48 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 11,250 | 0 | 15,606 | 4.4 K to 15.6 K (+258.26 %) |
| Mar 02 2016 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Grant | A | 0.00 | 4,356 | 0 | 4,356 | 0 to 4.4 K |
| Feb 25 2016 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | A | 6.67 | 74,987 | 500,163 | 74,987 | |
| Feb 25 2016 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | A | 6.67 | 15,013 | 100,137 | 15,013 | |
| Dec 02 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 1.24 | 4,920 | 6,101 | 80,968 | |
| Sep 02 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 1.21 | 5,109 | 6,182 | 76,048 | |
| Jun 02 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 0.90 | 6,972 | 6,275 | 70,939 | |
| Mar 03 2015 | OCLS | Oculus Innovative ... | BARBARI SHARON SURREY | Director | Option Exercise | A | 0.86 | 7,246 | 6,232 | 63,967 | |
| Mar 02 2015 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | A | 7.96 | 62,849 | 500,278 | 62,849 | |
| Mar 02 2015 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | A | 7.96 | 12,151 | 96,722 | 12,151 | |
| May 03 2004 | ITMN | INTERMUNE INC | BARBARI SHARON SURREY | Chief Financial Off ... | Buy | J | 12.58 | 680 | 8,554 | 2,041 | 1.4 K to 2 K (+49.96 %) |
Page: 1